Application of transcutaneous carbon dioxide improves capillary regression of skeletal muscle in hyperglycemia

J Physiol Sci. 2019 Mar;69(2):317-326. doi: 10.1007/s12576-018-0648-y. Epub 2018 Nov 26.

Abstract

The purpose of the present study was to determine the effects of transcutaneous CO2 application on the blood flow and capillary architecture of the soleus muscle in rats with streptozotocin (STZ)-induced hyperglycemia. Wistar rats were randomly divided into four groups: control, control + CO2-treated, STZ-induced hyperglycemia, and STZ-induced hyperglycemia + CO2-treated groups. Blood flow in soleus muscle increased during the transcutaneous CO2 exposure, and continued to increase for 30 min after the treatment. In addition, the transcutaneous CO2 attenuated a decrease in capillary and the expression level of eNOS and VEGF protein, and an increase in the expression level of MDM-2 and TSP-1 protein of soleus muscle due to STZ-induced hyperglycemia. These results indicate that the application of transcutaneous CO2 could improve capillary regression via the change of pro- and anti-angiogenesis factors, which might be induced by an increase in blood flow.

Keywords: Anti-angiogenesis factors; Blood flow; CO2 therapy; Diabetes; Muscle capillary; Pro-angiogenesis factors.

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Capillaries / drug effects*
  • Capillaries / metabolism
  • Carbon Dioxide / administration & dosage*
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Experimental / metabolism
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / metabolism
  • Male
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Rats
  • Rats, Wistar
  • Regional Blood Flow / drug effects
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Blood Glucose
  • Vascular Endothelial Growth Factor A
  • Carbon Dioxide
  • Nitric Oxide Synthase Type III